OC
| |
Octagon Capital Advisors LP13F | |
| Octagon Capital Advisors LP | |
| Last update 2025-05-16 | 35 Stocks (8 new) |
| Value $517.00 Mil | Turnover 27 % |
Octagon Capital Advisors LP Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NUVB.WS | Nuvation Bio Inc | 27,330,800 | 48,102.2 | +8,650.45% | 9.310 | +9.20% | - | 0% | 0% | 0 | Biotechnology | |
APLS | Apellis Pharmaceuticals Inc | 2,094,000 | 45,795.8 | -30.36% | 8.860 | -4.79% | 1.670 | -20.90% | -45.79% | 2,174.3 | Biotechnology | |
DNTH | Dianthus Therapeutics Inc | 2,341,667 | 42,477.8 | +10.97% | 8.220 | +0.81% | 7.280 | +2.70% | -14.54% | 599.1 | Biotechnology | |
AVBP | ArriVent BioPharma Inc | 2,059,387 | 38,078.1 | 0% | 7.370 | 0% | 6.020 | +17.58% | -18.39% | 743.8 | Biotechnology | |
TRVI | Trevi Therapeutics Inc | 3,322,000 | 20,895.4 | New Holding | 4.040 | +4.04% | 3.270 | -13.04% | +32.77% | 666.0 | Biotechnology | |
CNTA | Centessa Pharmaceuticals PLC | 1,425,000 | 20,491.5 | -28.50% | 3.970 | -1.56% | 1.070 | -8.62% | -21.55% | 1,755.8 | Biotechnology | |
GOSS | Gossamer Bio Inc | 18,350,000 | 20,185.0 | 0% | 3.910 | 0% | 8.080 | +11.82% | +35.97% | 279.6 | Biotechnology | |
OCUL | Ocular Therapeutix Inc | 2,425,000 | 17,775.3 | 0% | 3.440 | 0% | 1.520 | +26.60% | +8.67% | 1,478.3 | Biotechnology | |
MNMD | Mind Medicine Inc | 3,018,000 | 17,655.3 | 0% | 3.420 | 0% | 3.990 | +10.94% | -6.75% | 490.3 | Biotechnology | |
COGT | Cogent Biosciences Inc | 2,763,000 | 16,550.4 | 0% | 3.200 | 0% | 2.430 | +19.87% | -7.95% | 817.5 | Biotechnology |
Octagon Capital Advisors LP's Historical Top Holdings Breakdowns
Octagon Capital Advisors LP's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2025-03-31 | Reduce Reduce | -4.79% | 21.87 ($27.62) 34.63 | $17.30 | -37.36% | Reduce -30.36% | 2,094,000 | -912,980 | |
TRVI | Trevi Therapeutics Inc | 2025-03-31 | New Buy New Buy | +4.04% | 3.56 ($4.77) 6.81 | $5.47 | 14.68% | New holding | 3,322,000 | 3,322,000 | |
INSM | Insmed Inc | 2025-03-31 | Sold Out Sold Out | -3.77% | 65.25 ($76.49) 83.83 | $100.64 | 31.57% | Sold Out | 0 | -332,000 | |
VRNA | Verona Pharma PLC | 2025-03-31 | Reduce Reduce | -2.71% | 44.81 ($59.82) 69.63 | $94.54 | 58.04% | Reduce -61.97% | 217,264 | -354,000 | |
TRML | Tourmaline Bio Inc | 2025-03-31 | New Buy New Buy | +2.66% | 12.21 ($16.03) 21.74 | $16.02 | -0.09% | New holding | 905,000 | 905,000 | |
DYN | Dyne Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -2.59% | 10.46 ($14.3) 25.46 | $9.52 | -33.43% | Sold Out | 0 | -668,000 | |
MLTX | MoonLake Immunotherapeutics | 2025-03-31 | New Buy New Buy | +2.24% | 36.75 ($43.09) 53.57 | $47.21 | 9.56% | New holding | 296,000 | 296,000 | |
VSTM | Verastem Inc | 2025-03-31 | New Buy New Buy | +2.01% | 5.04 ($6.11) 7.53 | $4.15 | -32.08% | New holding | 1,720,000 | 1,720,000 | |
BBIO | BridgeBio Pharma Inc | 2025-03-31 | Sold Out Sold Out | -1.99% | 28.12 ($33.72) 37.59 | $43.18 | 28.05% | Sold Out | 0 | -441,600 | |
CNTA | Centessa Pharmaceuticals PLC | 2025-03-31 | Reduce Reduce | -1.56% | 14.38 ($16.36) 19.03 | $13.14 | -19.68% | Reduce -28.5% | 1,425,000 | -568,052 |
Octagon Capital Advisors LP Total Holding History ($B)
Octagon Capital Advisors LP's Asset Allocation
Octagon Capital Advisors LP Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Octagon Capital Advisors LP's Hypothetical Growth since 2025-03-31
Octagon Capital Advisors LP's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Octagon Capital Advisors LP's Holdings Heat Map
Size field:
Octagon Capital Advisors LP's Holdings Bubble Chart
Octagon Capital Advisors LP News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers